These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12059983)

  • 1. Relevance of apoptosis and cell proliferation for survival of patients with dilated cardiomyopathy undergoing partial left ventriculectomy.
    Metzger M; Higuchi ML; Moreira LF; Chaves MJ; Castelli JB; Silvestre JM; Bocchi E; Stolf N; Ramires JA
    Eur J Clin Invest; 2002 Jun; 32(6):394-9. PubMed ID: 12059983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results after partial left ventriculectomy versus heart transplantation for idiopathic cardiomyopathy.
    Etoch SW; Koenig SC; Laureano MA; Cerrito P; Gray LA; Dowling RD
    J Thorac Cardiovasc Surg; 1999 May; 117(5):952-9. PubMed ID: 10220690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy as a determinant of outcome following partial left ventriculectomy.
    Kanzaki Y; Terasaki F; Okabe M; Hayashi T; Toko H; Shimomura H; Fujioka S; Kitaura Y; Kawamura K; Horii Y; Isomura T; Suma H
    Jpn Circ J; 2001 Sep; 65(9):797-802. PubMed ID: 11548879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy.
    Zorc M; Vraspir-Porenta O; Zorc-Pleskovic R; Radovanović N; Petrovic D
    Cardiovasc Pathol; 2003; 12(1):36-9. PubMed ID: 12598016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyocyte apoptosis and progression of heart failure to transplantation.
    Saraste A; Pulkki K; Kallajoki M; Heikkilä P; Laine P; Mattila S; Nieminen MS; Parvinen M; Voipio-Pulkki LM
    Eur J Clin Invest; 1999 May; 29(5):380-6. PubMed ID: 10354194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy: light microscopic, immunohistochemical, and virological analyses of myocardium specimens obtained by partial left ventriculectomy.
    Terasaki F; Okabe M; Hayashi T; Fujioka S; Suwa M; Hirota Y; Kitaura Y; Kawamura K; Isomura T; Suma H
    J Card Surg; 1999; 14(2):141-6. PubMed ID: 10709829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial left ventriculectomy, ventriculoplasty or valvular surgery for idiopathic dilated cardiomyopathy - the role of intra-operative echocardiography.
    Isomura T; Suma H; Horii T; Sato T; Kikuchi N
    Eur J Cardiothorac Surg; 2000 Mar; 17(3):239-45. PubMed ID: 10758382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of partial left ventriculectomy in patients with end-stage idiopathic dilated cardiomyopathy.
    Dowling RD; Koenig S; Laureano MA; Cerrito P; Gray LA
    J Heart Lung Transplant; 1998 Dec; 17(12):1208-12. PubMed ID: 9883762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in Endomyocardial Biopsies from Patients with Dilated Cardiomyopathy.
    Glumac S; Pejić S; Kostadinovic S; Stojšić Z; Vasiljevic J
    Folia Biol (Praha); 2016; 62(5):207-211. PubMed ID: 27978416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of long-term mortality of current palliative surgical treatment for dilated cardiomyopathy.
    Moreira LF; Benício A; Bacal F; Bocchi EA; Stolf NA; Oliveira SA
    Eur J Cardiothorac Surg; 2003 May; 23(5):756-63; discussion 763-4. PubMed ID: 12754029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy.
    Di Napoli P; Taccardi AA; Grilli A; Felaco M; Balbone A; Angelucci D; Gallina S; Calafiore AM; De Caterina R; Barsotti A
    Am Heart J; 2003 Dec; 146(6):1105-11. PubMed ID: 14661007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation?
    Franco-Cereceda A; McCarthy PM; Blackstone EH; Hoercher KJ; White JA; Young JB; Starling RC
    J Thorac Cardiovasc Surg; 2001 May; 121(5):879-93. PubMed ID: 11326231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of midterm outcome of partial left ventriculectomy in dilated cardiomyopathy.
    Stolf NA; Moreira LF; Bocchi EA; Higuchi ML; Bacal F; Bellotti G; Jatene AD
    Ann Thorac Surg; 1998 Nov; 66(5):1585-91. PubMed ID: 9875756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial left ventriculectomy for idiopathic dilated cardiomyopathy: early results and six-month follow-up.
    Gradinac S; Mirić M; Popović Z; Popović AD; Nesković AN; Jovović L; Vuk L; Bojić M
    Ann Thorac Surg; 1998 Dec; 66(6):1963-8. PubMed ID: 9930477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial left ventriculectomy in pediatric end-stage dilated cardiomyopathy.
    Yoshii S; Suzuki S; Hosaka S; Osawa H; Takahashi W; Abraham SJ; Tada Y; Sugiyama H; Tan T; Kanazawa H
    Jpn J Thorac Cardiovasc Surg; 2002 Jun; 50(6):235-40. PubMed ID: 12073599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives of partial left ventriculectomy in the treatment of dilated cardiomyopathy.
    Moreira LF; Stolf NA; de Lourdes Higuchi M; Bacal F; Bocchi EA; Oliveira SA
    Eur J Cardiothorac Surg; 2001 Jan; 19(1):54-60. PubMed ID: 11163561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial left ventriculectomy with mitral valve preservation in the treatment of patients with dilated cardiomyopathy.
    Moreira LF; Stolf NA; Bocchi EA; Bacal F; Giorgi MC; Parga JR; Jatene AD
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):800-7. PubMed ID: 9576213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial left ventriculectomy: which patients can be expected to benefit?
    Frazier OH; Gradinac S; Segura AM; Przybylowski P; Popovic Z; Vasiljevic J; Hernandez A; McAllister HA; Bojic M; Radovancevic B
    Ann Thorac Surg; 2000 Jun; 69(6):1836-41. PubMed ID: 10892933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair.
    Kanoh M; Takemura G; Misao J; Hayakawa Y; Aoyama T; Nishigaki K; Noda T; Fujiwara T; Fukuda K; Minatoguchi S; Fujiwara H
    Circulation; 1999 Jun; 99(21):2757-64. PubMed ID: 10351969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight years survival after partial left ventriculectomy.
    Soo EN; Ascione R; Wilde P; Angelini GD
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):724-5. PubMed ID: 15784391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.